It’s been two years now for Bruce Power when they became the first commercial nuclear operator to produce lutetium-177, the cancer fighting isotope.
In the 24 months since commercial production began, Bruce Power and its partners have expanded their production to increase global demand who recently started a second production line.
This work has been done with partnerships with Isotope Production System, Saugeen Ojibway Nation, Isogen and ITM Isotope Technologies Munich SE.
Eric Chassard, Bruce Power President and Chief Executive Officer says through leveraging Bruce Power’s continual operations and thanks to the spirit and hard work of employees they have a stable, reliable source of cancer fighting isotopes which are sent to doctors, patients and researchers worldwide for use in targeted cancer therapies.
